GILDER GAGNON HOWE & CO LLC 13D and 13G filings for Magenta Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 06:09 am Sale |
2022-12-31 | 13G | Magenta Therapeutics, Inc. MGTA |
GILDER GAGNON HOWE & CO LLC | 425,858 0.700% |
-3,249,750 (-88.41%) |
Filing |
| 2022-02-14 07:04 am Sale |
2021-12-31 | 13G | Magenta Therapeutics, Inc. MGTA |
GILDER GAGNON HOWE & CO LLC | 3,675,608 6.300% |
-542,598 (-12.86%) |
Filing |
| 2021-02-16 10:04 am Purchase |
2020-12-31 | 13G | Magenta Therapeutics, Inc. MGTA |
GILDER GAGNON HOWE & CO LLC | 4,218,206 8.730% |
114,781 (+2.80%) |
Filing |